May 23, 2013 4:24 AM ET

Biotechnology

Company Overview of Pharmacopeia, Inc.

Company Overview

Pharmacopeia, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to address significant medical needs. Its internal program portfolio comprises PS433540, a dual-acting angiotensin and endothelin receptor antagonist, which is in phase II clinical development for the treatment of cardiovascular and renal diseases, including hypertension and diabetic nephropathy; and PS178990, a muscle selective SARM agonists that is in phase I clinical development. The company’s products also include PS031291, a preclinical development product for the treatment of multiple myeloma and various inflammatory diseases, including rheumatoid arthritis; and JAK3 inhibitors for...

Detailed Description

3000 Eastpark Boulevard

Cranbury, NJ 08512

United States

Founded in 1993

169 Employees

Phone:

609-452-3600

Fax:

609-452-3672

Key Executives for Pharmacopeia, Inc.

Founder
Age: 45
Senior Vice President of Clinical Development
Age: 54
Vice President of Preclinical Research
Age: 57
Compensation as of Fiscal Year 2012.

Similar Private Companies By Industry

Company Name Region
Phthisis Diagnostics, Inc. United States
Kardia Therapeutics, Inc. United States
Cellective Therapeutics, Inc. United States
Kyowa Hakko Kogyo Pharma, Inc. United States
Amunix, Inc. United States

Recent Private Companies Transactions

Type
Date		 Target
No transactions available in the past 12 months.
Report Data IssueReport Data Issue
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Pharmacopeia, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.

Close